-
admin
Posts
Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology-Healthcare Informatics
Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informatics SAN ANTONIO, Jan. 30, 2026 /PRNewswire/...
Allegro MicroSystems Reports Third Quarter 2026 Results
Sales Increased 29% Year-Over-Year and 7% Quarter-Over-Quarter to $229 Million MANCHESTER, N.H., Jan. 29, 2026 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro” or the “Company”)...
Bread Financial Provides Performance Update for December 2025
COLUMBUS, Ohio, Jan. 29, 2026 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and...
Bread Financial Declares Dividends on Preferred and Common Stock
COLUMBUS, Ohio, Jan. 29, 2026 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, flexible payment, lending...
Bread Financial Reports Fourth Quarter and Full Year 2025 Results
COLUMBUS, Ohio, Jan. 29, 2026 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, flexible payment, lending and...
South Korea B2C Ecommerce Market Forecast Report 2025-2029: Coupang, Naver, and SSG Lead, While AliExpress, Amazon (Cross-Border), and Omnichannel Retailers Lotte and Shinsegae Increase Pressure
Key market opportunities in South Korea’s ecommerce sector include ultra-fast delivery and logistics integration, cross-border ecommerce expansion, and live-commerce adoption. Growth in mobile payments and...
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for...
Kymera Therapeutics Announces First Patient Dosed in BREADTH Phase 2b Asthma Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis...
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation
Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings at 6 months compared with sham, with continued excellent safety and tolerability...
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture
A modern visual evolution designed to amplify artistic storytelling across the brand portfolio ATHENS, Ga., Jan. 29, 2026 (GLOBE NEWSWIRE) — Terrapin Beer Co. (Terrapin),...
